Strategic Plan: Opportunities and Future Directions
With significant improvements in cancer treatment, clinical trials have moved towards a precision medicine framework with scientific aims focused on optimizing QOL and minimizing toxicities while maintaining high survival rates. COG offers a unique collaborative environment to evaluate scientific aims with behavioral science outcomes in the context of large clinical trials with representative samples of children and AYAs with cancer from diverse racial, ethnic, and socioeconomic backgrounds. Aligned with our mission to improve outcomes for children with cancer and their families, the BSC is poised to contribute to the scientific advances of trials aiming to improve outcomes and promote evidence-based supportive care interventions to be translated into routine care.